Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 18, 2008, Pages 3137-3144

  Cai, Qingqing ^a,b   Huang, Huiqiang ^a,b   Sun, Xiaofei ^a,b   Xia, Zhongjun ^a,b   Li, Yuhong ^a,b   Lin, Xubin ^a,b   Guo, Ying ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

chemotherapy; mucositis; non cancerous pain; transdermal fentanyl

Indexed keywords

ANTINEOPLASTIC AGENT; FENTANYL; MOUTHWASH; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NAUSEA; PAIN; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUALITY OF LIFE; STOMATITIS; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; NAUSEA; PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STOMATITIS; TREATMENT OUTCOME; VOMITING; YOUNG ADULT;

EID: 59449094332     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656560802504508     Document Type: Article

References (33)

1. Pico JL, Avlia-Garavito A, Naccahine P. Mucositis. Its occurrence, consequences, and treatment in the oncology setting. Oncologist 1998;3:446-51
2. Radtke ML, Kolesar JM. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support. J Oncol Pharm Pract 2005;11:121-5
3. Worthington HV, Clarkson JE, Eden OB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007:CD001973
4. Grond S, Zech D, Lehmann KA, et al. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997;69:191-8
5. Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol 2008;19(suppl 2): 122-5
6. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168-75
7. Sloan PA, Moulin DE, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998;16:102-11
8. Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic effi cacy in pain control. Drugs 1997;53:109-38
9. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8
10. Kim JG, Sohn SK, Kim DH, et al. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplant Proc 2005;37(10):4488-91
11. Allen F. Diagnostic and statistical manual of mental disorders. 4th edition. Arlington: American Psychiatric Association; 1994
12. Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manage 2000;19:185-92
13. Mystakidou K, Befon S, Tsilika E, et al. Use of TTS as a single opioid for cancer pain relief: a safety and effi cacy clinical trial in patients naïve to mild or strong opioids. Oncology 2002;62:9-16
14. Finkel JC, Finley A, Greco C, et al. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer 2005;104(12):2847-57
15. Payne R, Chandler S, Einhaus M. Guidelines for the clinical use of transdermal fentanyl. Anticancer Drugs 1995;6(Suppl 3):50-3
16. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996;64:527-34
17. EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Available from: http://www.eortc.be/home/ qol/QLQ-C30.doc [Last accessed 23 October 2008]
18. Eisen D, Essell J, Broun ER Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997;16:265-72
19. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 2001;27(suppl 2):S3-11
20. Kostler WJ, Hejna M, Wenzel C, et al. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001;51:290-315
21. Coda BA, O'Sullivan B, Donaldson G, et al. Comparative effi cacy of patient-controlled administration of morphine, hydromorphine, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997;72:333-46
22. Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998;22:495-8
23. Zucker TP, Flesche CW, Germing U, et al. Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain 1998;75:305-12
24. Minkowitz HS, Rathmell JP, Vallow S, et al. Effi cacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med 2007;8(8):657-68
25. Tawfik MO, Bryuzgin V, Kourteva G. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin 2004;20(3):259-67
26. Huang H, Wang W. Case report: treating severe oral mucositis pain using transdermal fentanyl. Chin J Clin Oncol 2001;28(9):681
27. Strupp C, Sudhoff T, Germing U, et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 2000;7(3):659-61
28. Demarosi F, Lodi G, Soligo D, et al. Transdermal fentanyl in HSCT patients: n open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 2004;33(12): 1247-51
29. Clark AJ, Ahmedzai SH, Allan LG, et al. Effi cacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 2004;20(9): 1419-28
30. Gourlay GK. Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2001;2:165-72
31. Hanks GW, Nugent M, Higgs CM, et al. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med 2004;18(8):698-704
32. Darwish M, Kirby M, Robertson P, et al. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study. Clin Drug Investig 2007;27(9):605-11
33. Farrar JT, Troxel AB, Stott C, et al. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008;30(5):974-85